Evidence map›Paper›PMID 23460839›Full record

ArticlePloS one2013

Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer.

Mikhail Soloviev, Michelle P Esteves, Fakhria Amiri, Mark R Crompton, Christopher C Rider

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Role of Nkx3.1 in Cancers and Stemness.International journal of stem cells · 2021
    Review
  11. Article
  12. Article
  13. Characterization of a Sulfhydryl Oxidase FromFrontiers in cellular and infection microbiology · 2020
    Article
  14. Molecular Inhibitor of QSOX1 Suppresses Tumor GrowthMolecular cancer therapeutics · 2020
    Article
  15. Article
  16. QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2016
    Article
  17. Article
  18. Article
  19. The emerging role of QSOX1 in cancer.Antioxidants & redox signaling · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mikhail SolovievSchool of Biological Sciences, Centre for Biomedical Sciences, Royal Holloway University of London, London, United Kingdom. mikhail.soloviev@rhul.ac.uk
Michelle P Esteves
Fakhria Amiri
Mark R Crompton
Christopher C Rider
Royal Holloway University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The q arm of chromosome 1 is frequently amplified at the gene level in breast cancer. Since the significance of this is unclear we investigated whether 1q genes are overexpressed in this disease. The cDNA levels of 1q-located genes were analysed in a search for overexpressed genes. 26 genes mapping to the 1q arm show highly significant (P≤0.01) overexpression of transcripts in breast cancer compared to normal breast tissue. Amongst those showing the highest levels of overexpression in both expressed sequence tag (EST) and serial analysis of gene expression (SAGE) databases was enzyme quiescin Q6 sulfhydryl oxidase 1 (QSOX1). We investigated QSOX1 cDNA derived from T47D breast carcinoma cells by RT-PCR and 3'-RACE PCR and identified a novel extended form of QSOX1 transcript, containing a long 3'UTR, nearly double the size of the previously reported QSOX1 cDNA, and confirmed its 3' end nucleotide sequence using RACE-PCR. We also used quantitative real-time PCR to analyse a panel of cDNAs derived from 50 clinically-graded normal and malignant breast tissue samples for the expression of QSOX1 mRNAs. QSOX1 transcription was elevated in an increasing proportion in the grade 2 and grade 3 tumours (graded according to the Nottingham prognostic index), with 10 of the 15 grade 3 tumours (67%) examined exceeding the normal range. There was a significant correlation between relative transcript level and clinical grade (P≤0.01) for all qPCR primer sets tested. QSOX1 mRNA levels, based on SAGE expression data, did not correlate with either Estrogen Receptor (ER) or Epidermal Growth Factor Receptor 2 (ErbB-2 or HER2/neu) expression. Our data indicate that QSOX1 is a potential new prognostic marker which may prove of use in the staging of breast tumours and the stratification of breast cancer patients.

Indexed as

Gene Expression Regulation, NeoplasticTranscription, GeneticAlternative SplicingBase SequenceBreast NeoplasmsCarcinoma, Ductal, BreastCell Line, TumorDNA, ComplementaryExpressed Sequence TagsFemaleGenes, NeoplasmHumansMolecular Sequence DataOpen Reading FramesOxidoreductases Acting on Sulfur Group DonorsProtein BiosynthesisDNA, ComplementaryOxidoreductases Acting on Sulfur Group DonorsQSOX1 protein, humanRNA, Messenger

Identifiers

PMID23460839
PMCPMC3583868
OpenAlexW2014266068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.